(Q37853484)

24 August 2017

1 reference

title

Guidelines 2.0: do no net harm-the future of practice guideline development in asthma and other diseases (English)

1 reference

24 August 2017

0 references

1

Holger J Schünemann

1 reference

24 August 2017

publication date

1 June 2011

1 reference

Current Allergy and Asthma Reports

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

261-268

1 reference

GRADE system: new paradigm

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Transparent development of the WHO rapid advice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

A vision statement on guideline development for respiratory disease: the example of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Why guideline-making requires reform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

An official American Thoracic Society Policy statement: managing conflict of interest in professional societies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

WHO: the casualties and compromises of renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

25 years of the WHO essential medicines lists: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

A time to ask what you want of WHO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Final report of the Lyme disease review panel of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Assessing faculty financial relationships with industry: A case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Doctors and drug companies--scrutinizing influential relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

The vexing problem of guidelines and conflict of interest: a potential solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

When are randomised trials unnecessary? Picking signal from noise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

A framework for mandatory impact evaluation to ensure well informed public policy decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

AGREE II: Advancing guideline development, reporting and evaluation in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Critics slam draft WHO report on homoeopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

The Next Step in Guideline Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-011-0185-8

Financial Conflict of Interest Disclosure and Voting Patterns at Food and Drug Administration Drug Advisory Committee Meetings

21 January 2018

1 reference

12 December 2020

Practice guidelines developed by specialty societies: the need for a critical appraisal

1 reference

12 December 2020

Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report

1 reference

12 December 2020

Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders

1 reference

12 December 2020

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

1 reference

12 December 2020

GRADE: assessing the quality of evidence for diagnostic recommendations

1 reference

12 December 2020

Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations

1 reference

12 December 2020

Guideline funding and conflicts of interest: article 4 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report

1 reference

12 December 2020

Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest

1 reference

12 December 2020

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

1 reference

12 December 2020

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines

1 reference

12 December 2020

10.1007/S11882-011-0185-8

Identifiers

DOI

1 reference

release_f7zzlvjksbah3k7ou5kdxepnle

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f7zzlvjksbah3k7ou5kdxepnle

24 November 2022

mapped directly with Wikidata item

1 reference